Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Prepaid Assets (2016 - 2025)

Editas Medicine (EDIT) has disclosed Prepaid Assets for 11 consecutive years, with $3.1 million as the latest value for Q3 2025.

  • On a quarterly basis, Prepaid Assets fell 47.46% to $3.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was $3.1 million, a 47.46% decrease, with the full-year FY2024 number at $3.1 million, down 58.36% from a year prior.
  • Prepaid Assets was $3.1 million for Q3 2025 at Editas Medicine, down from $3.7 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $9.5 million in Q3 2021 to a low of $3.1 million in Q3 2025.
  • A 5-year average of $6.3 million and a median of $6.7 million in 2023 define the central range for Prepaid Assets.
  • Peak YoY movement for Prepaid Assets: soared 58.2% in 2024, then crashed 63.14% in 2025.
  • Editas Medicine's Prepaid Assets stood at $7.2 million in 2021, then rose by 1.9% to $7.3 million in 2022, then rose by 2.67% to $7.5 million in 2023, then plummeted by 58.36% to $3.1 million in 2024, then dropped by 0.73% to $3.1 million in 2025.
  • Per Business Quant, the three most recent readings for EDIT's Prepaid Assets are $3.1 million (Q3 2025), $3.7 million (Q2 2025), and $3.4 million (Q1 2025).